1. Oncology pharmaceuticals: reproductive toxicity testing and labeling recommendations Publication: Silver Spring, MD : Center for Drug Evaluation and Research, May 2019 Subject(s): Antineoplastic Agents -- adverse effectsMutagenicity Tests -- standardsNeoplasms -- drug therapyReproduction -- drug effectsTeratogensToxicity Tests -- standardsContraceptionDrug-Related Side Effects and Adverse ReactionsFertilityGeriatricsPediatricsPostmenopauseHumansUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
